Livongo is a US based consumer digital health company that empowers people with chronic conditions to live better and healthier lives. Livongo has developed a new approach for diabetes management that combines the latest technology with coaching.

On 11 April 2018, Kinnevik announced an investment of USD 41m in Livongo, leading a USD 105m funding round and increasing the ownership to 8%.
Read more in our Press Release >

“We are excited to lead the funding round in Livongo and to increase our ownership in the company. Since our first investment a year ago, Livongo has grown its member base by 2.5 times and reinforced its position as a leader in chronic conditions, starting with diabetes. We have set out to focus our private portfolio and to identify the winners, and the investment in Livongo is an important step in executing our strategy in this area.”

- Kinnevik's CEO Georgi Ganev



Kinnevik stake

SEK 700m

Fair value 31 Dec 2018